Trial Profile
Aliskerin Effect on Plaque Progression in Established Atherosclerosis Using High Resolution 3D MRI: A Double Blind Placebo Controlled Trial.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary)
- Indications Atherosclerosis
- Focus Therapeutic Use
- Acronyms ALPINE
- 01 Jan 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 01 Jan 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 15 Aug 2011 Planned end date changed from 1 May 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov (NCT01417104).